|
InvestorInstantMessaging: Progress Review For Applera Corp-Applied
Biosystems Group
(M2 PressWIRE Via Thomson Dialog NewsEdge)
RDATE:27032008
InvestorIM has been created as a tool for the average investor. The
idea is simple, a website where the world can communicate. Do you have
a stock related question, then why not ask 50,000 individual members?
Are you a shareholder of Applera Corp-Applied Biosystems Group
(NYSE:ABI) Join the many members engaged in this stock right now. Come
see for yourself at www.investorim.com for your complimentary
subscription.
End of day trading, Applera Corp-Applied Biosystems Group opened up
$0.50 on below its average volume. Today, March 26, 2008, Applied
Biosystems, an Applera Corporation business, announced a new family of
real-time PCR reagent kits that enable researchers to more rapidly
perform cell-based gene expression research. The TaqMan Cells-to-CT Kit
solutions are chemical reagents that are designed to reduce the amount
of time that is typically necessary to prepare and analyze RNA from
cultured cells using real-time PCR in applications such as
siRNA-mediated gene silencing and microRNA analysis.
Applera Corporation-Applied Biosystems Group develops and markets
instrument-based systems, consumables, software, and services. Its
products and services are used in basic human disease research and
genetic analysis; pharmaceutical drug discovery, development, and
manufacturing; agriculture research; human identity testing;
biosecurity; and quality and safety testing. The company's products
include PCR (polymerase chain reaction) and Real-Time PCR Systems and
related consumables, including amplification instruments, , various
combination thermal cyclers, PCR detection systems, and reagents,
disposables, and software necessary for the PCR amplification and
detection process; Genetic Analysis Instruments for performing both DNA
sequencing and fragment analysis; Capillary Electrophoresis and Next
Generation Systems for analyzing DNA molecules using a process referred
to as capillary electrophoresis; Genomic Assays, which are a set of
pre-selected oligonucleotides, used to measure a DNA or RNA target;
reagents associated with RNA interference, referred to as RNAi, and
products for the analysis of microRNA, referred to as miRNA; sample
preparation products, used to isolate and purify RNA; and reagents used
to convert an RNA sample into DNA; and reagents for PCR amplification.
The company also offers products used for the study of cell and
biological molecule function; mass spectrometry products,
biochromatography media products, and protein sequencing and synthesis
systems; and products for the small molecule analysis market. Applied
Biosystems also develops and markets products for forensic testing and
human identification, biosecurity, pharmaceutical manufacturing, and
food testing. It also develops, markets, and distributes software
products for laboratory information management systems. The company was
founded in 1937 and is headquartered in Norwalk, Connecticut.
Disclaimer All material listed within InvestorIM ("Profiles") was based
upon information supplied by the company or from other sources believed
to be reliable. The information contained in our Profiles is not
guaranteed by InvestorIM to be accurate and should not considered to be
all-inclusive. The companies discussed on Profiles except for those
companies that appear on the InvestorIM have not approved the
statements made herein. Any discussions and pages contain forward
looking statements that involve risks and uncertainties. A company's
actual results could differ materially from those described in any
forward - looking statements or announcements discussed on Profiles.
All material is for informational purposes only and should not be
construed as an offer or solicitation of an offer to buy or sell
securities. InvestorIM is not a licensed broker, broker dealer, market
maker, investment banker, investment advisor, analyst, or underwriter.
Companies profiled at InvestorIM are ineligible for recommendations on
InvestorIM for 90 days following final disposition of any compensation.
InvestorIM will not trade in a security featured as a street tip on
this site before the recommendation and not until the recommendation is
posted in the main site, unless disclosed when the pick is made. We
have the right to sell before targets that are posted on the stock.
You are responsible for your own trading/investing decisions. Use of
this site means you have read and understand and accept these terms of
use and disclaimer of our liability.
The Financial Information and Financial Content provided by InvestorIM
is for informational purposes only and should not be used or construed
as an offer to sell, a solicitation of an offer to buy, or endorsement,
recommendations, or sponsorship of any company or security by
InvestorIM. You acknowledge and agree that any request for information
is unsolicited and shall neither constitute nor be construed as
investment advice by InvestorIM to you. It is strongly recommended that
you seek outside advice from a qualified securities professional prior
to making any securities investment. InvestorIM does not provide or
guarantee any legal, tax, or accounting advice or advice regarding the
suitability, profitability, or potential value of any particular
investment, security, or informational source.
You acknowledge and agree that any reliance upon the Financial
Information or Financial Content available through links accessible
through InvestorIM is at your own sole risk. InvestorIM is not
responsible for any Financial Information or Financial Content posted
by any third party.
InvestorIM may invest or otherwise hold interests in companies
contemplating or that have undertaken initial public offerings.
InvestorIM does not guarantee the reliability or accuracy of any
Financial Information or Financial Content available through
InvestorIM. The views and opinions expressed in the Financial
Information or the Financial Content are not intended to constitute a
description of securities bought, sold, or held on behalf of InvestorIM.
Nor are such views and opinions an indication of any intention to buy,
sell, or hold any security by InvestorIM and investment decisions made
by InvestorIM may change at any time and for any reason.
The Financial Information and the Financial Content are not intended to
constitute investment advice or a recommendation to buy, sell, or hold
any security.
Some of the information and Content available through InvestorIM is
obtained from third parties. Such third parties are solely responsible
for the information or content they make available through InvestorIM.
Investing in securities carries certain risks, and InvestorIM nor any
Investment Information is not responsible for any investment losses
incurred in reliance on information provided at InvestorIM. ADVICE FROM
YOUR OWN FINANCIAL ADVISOR IS STRONGLY RECOMMENDED.
When using InvestorIM concerning investments and securities, investors
should be wary and cautions of any information they find. Information
obtained through these sources, or through any other aspect of the
Products and Services offered by InvestorIM, cannot be a substitute for
independent research into particular companies, industries, and
investments. Investment or trading decisions should not be based on
information obtained through InvestorIM. The information made available
may be incorrect; InvestorIM disclaims all responsibility and liability
for the Content and its accuracy. The Content is provided solely for
the entertainment of users.
In conjunction with the Gramm-Leach-Bliley Act, InvestorIM does not
disclose any "non public information" regarding our users. None of our
information is passed to third parties in whole or in part.
((M2 Communications Ltd disclaims all liability for information
provided within M2 PressWIRE. Data supplied by named party/parties.
Further information on M2 PressWIRE can be obtained at
http://www.presswire.net on the world wide web. Inquiries to
info@m2.com)).
Copyright ? 2008 M2 Communications Ltd.
[ Back To TMCnet.com's Homepage ]
|
